Treatment of herpes infectionusing immunomodulatory polynucleotide sequences

Details for Australian Patent Application No. 2001281459 (hide)

International Classifications

Event Publications

15 September 2005 Application Accepted

Published as AU-B-2001281459

29 September 2005 Corrigenda

Applications Accepted - Name Index Under the name Dynavax Technologies Corporation, Application No. 2001281459, under INID (54) correct the title to read Treatment of herpes infection using immunomodulatory polynucleotide sequences.

19 January 2006 Standard Patent Sealed

30 March 2006 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 16 Feb 2006. Address for service in Australia - FB Rice & Co Level 23 200 Queen Street MELBOURNE VIC 3000

31 August 2006 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 16 Feb 2006, 09 March 2006 2002

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.